Product
Paclitaxel Protein Bound
1 clinical trial
3 indications
Indication
Pancreatic CancerIndication
Pancreatic adenocarcinomaIndication
Neoadjuvant Pancreatic CancerClinical trial
A Phase II Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Paricalcitol as Pre-operative Treatment in Patients With Untreated Resectable, Borderline Resectable and Locally Advanced Adenocarcinoma of the PancreasStatus: Active (not recruiting), Estimated PCD: 2023-12-31